These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 39197915)
1. Sequential Moderate Hypofractionated Boost in Breast Cancer Patients: A Monoinstitutional Analysis of Late Side Effects. Palumbo I; Becchetti AG; Perrucci E; Falcinelli L; Saldi S; Bini V; Aristei C Anticancer Res; 2024 Sep; 44(9):3965-3971. PubMed ID: 39197915 [TBL] [Abstract][Full Text] [Related]
2. Hypofractionated whole breast radiotherapy with or without hypofractionated boost in early stage breast cancer patients: a mono-institutional analysis of skin and subcutaneous toxicity. Palumbo I; Mariucci C; Falcinelli L; Perrucci E; Lancellotta V; Podlesko AM; Marcantonini M; Saldi S; Bini V; Aristei C Breast Cancer; 2019 May; 26(3):290-304. PubMed ID: 30341747 [TBL] [Abstract][Full Text] [Related]
3. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial. Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706 [TBL] [Abstract][Full Text] [Related]
4. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer. Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952 [TBL] [Abstract][Full Text] [Related]
5. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543 [TBL] [Abstract][Full Text] [Related]
6. Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study. Meattini I; Poortmans P; Kirova Y; Saieva C; Visani L; Salvestrini V; Kim J; Jung W; Olmetto E; Mariotti M; Desideri I; Fourquet A; Livi L; Kim K Acta Oncol; 2020 Feb; 59(2):188-195. PubMed ID: 31760849 [No Abstract] [Full Text] [Related]
7. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Deantonio L; Gambaro G; Beldì D; Masini L; Tunesi S; Magnani C; Krengli M Radiat Oncol; 2010 Nov; 5():112. PubMed ID: 21092288 [TBL] [Abstract][Full Text] [Related]
8. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study). De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035 [TBL] [Abstract][Full Text] [Related]
9. Significance of Hypofractionated Radiotherapy in Postoperative Irradiation for Breast Cancer: An Asian Multi-institutional Prospective Study. Okonogi N; Kono S; Karasawa K; Banu PA; Xu X; Erawati D; Adylkhanov T; Jang WI; E Y; Calaguas MJ; Thephamongkhol K; Dung TA; Ng WNP; Kato S; Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):463-471. PubMed ID: 37179216 [TBL] [Abstract][Full Text] [Related]
10. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation. Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257 [TBL] [Abstract][Full Text] [Related]
11. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis. Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315 [No Abstract] [Full Text] [Related]
12. Hypofractionated whole breast irradiation in association with hypofractionated or normofractionated boost to the tumor bed in early breast cancer: tolerance and efficacy analysis. Oses G; Barreto TD; Cases C; Muñoz-Guglielmetti D; Antelo G; Mollà M Clin Transl Oncol; 2023 Aug; 25(8):2419-2426. PubMed ID: 36947361 [TBL] [Abstract][Full Text] [Related]
13. 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost. Gupta A; Khan AJ; Yegya-Raman N; Sayan M; Ahlawat S; Ohri N; Goyal S; Moore DF; Eladoumikdachi F; Toppmeyer D; Haffty BG Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):267-274. PubMed ID: 31175905 [TBL] [Abstract][Full Text] [Related]
14. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery. Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835 [TBL] [Abstract][Full Text] [Related]
15. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors. Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083 [TBL] [Abstract][Full Text] [Related]
17. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity. Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613 [TBL] [Abstract][Full Text] [Related]
18. Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials. Pfaffendorf C; Vonthein R; Krockenberger-Ziegler K; Dellas K; Schreiber A; Uhlemann D; Dinges S; Würschmidt F; Andreas P; Weinstrauch E; Eilf K; Rades D; Höller U; Combs SE; Kazmierczak R; Fehlauer F; Schreck U; Zimmer J; Dunst J; Krug D Breast; 2022 Aug; 64():136-142. PubMed ID: 35691249 [TBL] [Abstract][Full Text] [Related]
19. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up. Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997 [TBL] [Abstract][Full Text] [Related]
20. Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study. Tokuda PJK; Mitsuyoshi T; Ono Y; Kishi T; Negoro Y; Okumura S; Ikeda I; Sakamoto T; Kokubo Y; Ashida R; Imagumbai T; Yamashita M; Tanabe H; Takebe S; Tokiwa M; Suzuki E; Yamauchi C; Yoshimura M; Mizowaki T; Kokubo M; Breast Cancer; 2024 Jul; 31(4):643-648. PubMed ID: 38607499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]